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Introduction
Itch an unpleasant sensation that elicits the desire or reflex to scratch [1, 2] . The sensation of itch shares a number of similar characteristics with pain and is likely transmitted by certain unmyelinated C fibers in the peripheral nerve that was classified as nociceptor or, more specifically, pruriceptors [3, 4] . Antigen-specific immune diseases such as atopic and allergic dermatitis are often accompanied with pathological itch as well as pain [5, 6] . Patients with allergic disorders usually have an elevated level of antigen-specific immunoglobulin (Ig), especially IgE in the serum [5] . IgE may bind with specific allergen forming immune complex (IC). IgE-IC can induce itch via three steps: IgE-IC activate immune cells via Fc epsilon receptor (FcεR); activated immune cells release pro-inflammatory mediators and pruritogens (such as histamine, tryptase, cytokines); pruritogens induce itch by activating peripheral sensory neurons [7] [8] [9] . It has been well known that IgE may activate certain immune cells such as mast cells upon binding with allergen and trigger a series of immune responses which can produce itch and/or pain. However, current therapeutics targeting histamine receptors or mast cells do not always effectively relieve the discomfort of itch or stop the destructive behavior which can produce tissue damage in certain pathological conditions such as allergic conjunctivitis or dermatitis.
FcεR type I (FcεRI) is the high-affinity activating receptor that binds to the Fc portion of IgE.
FcεRI has been defined structurally as a trimeric form (αγ 2 ) or a tetrameric form (αβγ 2 ) [7, 10] . The α-chain containing two immunoglobulin-type domains is the IgE binding chain. The β-and γ-chains contain conserved immunoreceptor tyrosine-based activation motifs (ITAMs) [7] [8] [9] [10] [11] . FcεRI typically expresses on immune cells (such as mast cell in skin and mucosa, or basophils in blood vessels). As suggested in a previous report [12, 13] and in our pilot studies [14, 15] , FcεRI may express in dissociated mouse dorsal root ganglia (DRG) neurons but the function of neuronal FcεRI was unknown. It was not clear whether the peripheral sensory neurons could be directly activated by IgE-IC.
We hypothesize that a subpopulation of peripheral nociceptive (including pruriceptive) neurons that express FcεRI can be directly activated by IgE-IC inducing itch and/or pain. Furthermore, the expression of neuronal FcεRI and responses to IgE-IC may be modulated in allergic diseases therefore contributing to the exaggerated pruritus in such conditions. We tested these hypotheses in ovalbumin allergic mouse model of ocular itch. Our findings revealed a novel neural mechanism for the sensation of itch, and might suggest potential therapeutic strategies for the treatment of pruritus related to allergic diseases.
Materials and Methods

Animals
and then diluting to the concentrations of 0.01, 0.1, 0.3，and 1µg/ml. In control experiments, individual components of IC (i.e. mouse anti-OVA IgE, OVA) were applied.
Sensitization and challenging of mice
A mouse model of ovalbumin sensitization induced ocular itch was produced with the following procedures: on day 0, day 7 and day 14, i.p. injection of 100µg OVA plus 100µL Imject Alum dissolved in 400 µL of normal saline. On days 21, 10 µL of OVA (0.001% to 5% in normal saline)
were applied topically to both eyes to induce ocular allergy [18] .
Behavioral assessment for ocular itch and pain
Behavioral assessment for ocular itch and pain in the mice were preformed following the procedures as described in previous publications [19, 20] . Briefly, mice were placed in an acrylic box (13×9×40 cm) in a sound-proof room without persons for 3 consecutive days before and 1h on the day of recording to allow acclimation. They were returned to the same box immediately after drug administration, and were videotaped from the top of box with a high-resolution digital camera (SONY HANDYCAM HDR-PJ580E, Japan) for 1 h. Four mirrors were placed on the sides of the box for a better observation of the mouse behavior. The numbers of bout of scratching the treated eye with its hindpaw or wiping with the ipsilateral forelimb were counted during video playback.
Measurement of serum total and special IgG and IgE
The total IgG or IgE in the mouse serum were assessed using the mouse IgG or IgE ELISA kit (eBioscience), respectively. Briefly, Corning Costar 9018 ELISA plate was coated overnight at 4°C with capture antibody. Coated wells were blocked with Blocking Buffer at room temperature.
Samples were diluted at 10,000-fold for IgG or 25-fold for IgE. Total IgG was detected using HRP-conjugated anti-mouse IgG monoclonal antibody; total IgE was detected using biotin-conjugated anti-mouse IgE and Streptavidin-HRP monoclonal antibody as a second-step reagent，according to the manufacturer's instructions. Similarly, the OVA-specific IgG 1 or IgE were measured using a Mouse OVA IgG 1 or IgE ELISA kit (Cayman, Maine, USA), respectively.
Cell dissociation and culture
TG neurons were dissociated and cultured from adult C57BL/6 mice. Briefly, TGs of both sides were harvested from the skull base of decapitated mice after quick removal of brain, and transferred into oxygenated complete saline solution (CSS) for cleaning and mincing as previously reported [21] .
The TGs were then digested with Liberase TM for 20 min and for another 20 min with Liberase TL and papain in CSS containing 0.5 mM EDTA at 37°C. After enzymatic digestion, the cells were dissociated by gentle trituration with a fire-polished Pasteur pipette in culture medium containing 0.5mg/ml bovine serum albumin and 0.5mg/ml trypsin inhibitor and placed on poly-D-lysine/laminin-coated 12-mm diameter circular glass coverslips (BioCoat, BD Biosciences).
The culture medium contained equal amounts of DMEM and F12 with 10% FBS. The cells were maintained at 37°C in a humidified atmosphere of 95% air and 5% CO 2 and were used within 24 h.
Immunohistochemistry
Immunohistochemistry for dissociated TG neurons: TG cells cultured for 18-24 h were post-fixed in cold 80% acetone for 0. and large-sized (> 35µm).
Western blotting
Freshly harvested mouse TG tissue or dissociated TG neurons were homogenized in modified RIPA buffer with protease inhibitors. The homogenates (25µg of protein) were separated by SDS-PAGE and transferred to a PVDF membrane. After incubation in 5% BSA solution for 1 h, the membranes were followed by overnight incubation at 4°C with the one of the primary antibodies:
hamster anti-FcεRIα (1:1,000) mouse anti-FcεRIβ (1:100, Santa Cruz Biotechnology), rabbit anti-FcεRIγ (1:300) and mouse anti-β-actin (1:800). Subsequently, the membrane was incubated with the corresponding HRP-conjugated anti-IgG antibody (goat anti-hamster IgG, 1:1,500; goat anti-mouse IgG, 1:4000 and goat anti-rabbit IgG, 1:4000). Bands were determined using eECL Kit.
Quantitative RT-PCR
Total RNA was extracted from TG neurons with TriZol Reagent. Then cDNA was synthesized from 500ng by using the prime script RT Master Mix according to the manufacturer's protocol.
Approximately 100ng RNA-equivalent cDNA template was used per well, and qRT-PCR was performed using a CFX96™ Real-Time PCR Detection System (Bio-Rad) with SYBR premix Ex Taq TM . The sequences of primers for FcεRIα, FcεRIβ, FcεRIγ and β-Actin control are presented in Table 1 .
Small interfering RNA transfection
TG neurons were transfected with either a Stealth small interfering RNA (siRNA) or a Stealth
RNAi negative control (Invitrogen) using the Lipofectamine ® RNAi MAX Reagent according to the manufacturer's instructions. The target sequences of the Stealth siRNAs were 5′GCUAUGGGAACAAUCACCUUCAAAU3′ and 5′AUUUGAAGGUGAUUGUUCCCAUAGC3′
for FcεRIα; and Stealth TM RNAi Negative Control Duplexes (Medium GC) for the scrambled control of FcεRIα. After 6 h treatment with siRNA, the medium was changed with DMEM containing 10%
FCS, and the cells were incubated for 24h. The neurons without the addition of siRNA to the transfection reagents were used as an empty vector negative control.
Intracellular calcium imaging
Intracellular calcium imaging was performed as described before [21, 22] . Cultured mouse TG neurons were incubated with Fura 2-acetoxy-methyl ester (2µM) in the dark for 45 min at 37 °C.
After loading with calcium sensitive dye, TG neurons were washed twice in HEPES buffer to remove extracellular dye, and placed in a recording chamber continuously perfused with HEPES buffer at a flow rate of 1.5 ml/min at room temperature. Images were recorded using an upright NIKON ECLIPSE Ti microscope equipped with a ratiometric imaging system (Nikon NIS-Elements 
Statistical analysis
Data values are presented as means with standard errors (mean ± SEM). Statistical analyses were performed using the SPSS software (version 17.0). A Student′s t-test was used to evaluate the statistical significance of a difference between mean responses of two groups. Statistical comparisons of differences among three or more groups were made with a one-way analysis of variance (ANOVA)
followed by Scheffe′s post hoc test. Chi-square tests were used to compare between two or more incidence of events. The criterion for statistical significance was a value of P < 0.05.
Results
Scratching with the hindlimb as a indicator for ocular itch in the mice
It has been reported that scratching with the hindlimb is a behavioral indicator of pruritic stimuli to the cheek of mice, and wiping with forelimb is an indicator of pain [19] . We first tested that such a behavior model also applies to the eyes in naïve mice. When capsaicin solution (5 µl, 5 µM freshly prepared in 0.1% Tween 20) was dropped to the eye, a stimulation that produces ocular irritation/pain in human, the mice demonstrated a significant increase of wiping with the forelimb toward the eye, but not a significant increase of scratching with the hindlimb as compared to the vehicle (Fig. 1A-B) .
In contrast, when a pruritogen Bam8-22 (5 µl, 10 µM in saline) [17, 23] was dropped to the eye, the mice showed significant increase of scratching but not wiping toward the eye (Fig. 1A-B ). Therefore we concluded that scratching with the hindlimb is an indicator for ocular itch while wiping with hindlimb is an indicator for ocular pain in the mice.
A mouse model of antigen-specific ocular pruritus
We produced a mouse model of ocular pruritus via topical application of a specific antigen to the eyes of antigen-sensitized mice. Immunization with either OVA alone or OVA and alum adjuvant (OVA+alum) significantly increased the serum concentration of total IgG and allergen-specific IgG 1 , although the IgG and IgG 1 concentrations were much less in the OVA-alum group (Fig. 1C-D) .
However, a significantly increased serum concentration of total IgE and allergen-specific IgE are found only in the mice sensitized with OVA+alum, but not in those sensitized with OVA alone (Fig.   1E-F ).
Pruritic and painful responses to OVA allergen were examined in the mice according to the assay established above in 3.1. Topical application of allergen (OVA 0.1%-5%, 5uL dropped to the eye) dose-dependently induced a pruritic response, i.e. hind-paw scratching of the treated eye in
OVA+alum sensitized mice but not in the naïve or OVA sensitized mice (Fig. 1G ). There was no significant change in pain-related behavior, i.e. wiping of the eyes in any of these groups (Fig. 1G ).
Among all doses tested, topical application of 1% OVA evoked the highest scratching responses (Fig.   1G-H) , which started almost immediately after challenge, peaked during the first 10 min, and decreased gradually in 60 mins (Fig. 1I) . Compared to the naïve or OVA sensitized groups, the number of scratching bouts/hr was significantly higher in the OVA+alum sensitized mice immediately or at 24 hrs after OVA challenging, but not at 12 hrs after challenging (Fig. 1J) .
In order to examine the role of mast cell degranulation, histamine release and FcεRI in the allergen-evoked ocular pruritus, we pre-administrated a mast cell stabilizer cromolyn sodium (6% in 
Expression of neuronal FcεRI in the TG
FcεRI was known to express on proinflammatory cells (such as in mast cells or basophils) in tetrameric form (αβγ 2 ) [7, 8, 11, 24] . Using double immunofluorescent staining, we found that the FcεRIα, β and γ were expressed on the surface of dissociated TG neurons that were immunopositive for neuron specific marker protein PGP9.5 ( Fig. 2A-I ). We also found that the conjunctival mucosa was innervated by FcεRIα positive neurons, as indicated by DiI tracer injected into the conjunctiva (Supplementary Fig. S1A-C) . In two transgenic mice lines with GFP expressed in tentative pruriceptive neurons (MrgprA3 + or MrgprD + ) [16, 17] , we found that 23.1% FcεRIα immunopositive neurons co-express MrgprA3, and 27.3% FcεRIα immunopositive neurons co-express MrgprD ( Supplementary Fig. S1D-I ). Immunofluorescent staining using the polyclonal and monoclonal antibodies produced similar results on cryosections of TG ( Supplementary Fig. S2 ). These findings suggested that functional FcεRI might express in pruriceptive TG neurons innervating the conjunctiva.
Next, qPCR and western blotting was used to detect the expression of all three subunits of FcεRI (α, β and γ) in the TG of naïve and sensitized mice. The results showed that mRNA and protein levels of FcεRIα in TG were significantly increased in OVA+alum sensitized mice. Only the mRNA, but not protein level of FcεRIα were found significantly increased in OVA sensitized mice (Fig.   3A-B) . Immunofluorescent staining indicated that the increased FcεRIα was only detected in small-sized TG neurons (somal diameter < 25µm), but not in large-or medium-sized neurons in the TG (Fig. 3C-F) . The mRNA and protein levels of FcεRIβ were found significantly increased in the OVA+alum sensitized mice (Fig. 4A-B) . Immunofluorescent staining showed the increased immunoreactivity of FcεRIβ in the TG neurons ( Fig. 4C-D) . For FcεRIγ, significantly increased mRNA level was found in both the OVA and OVA+alum sensitized mice (Fig. 4F ), but the western blotting ( Fig. 4G ) and immunofluorescent staining ( Fig. S3 ).
IgE-IC induced [Ca 2+ ] i increase in the TG neurons via FcεRI
We further examined whether neuronal FcεRI could be directly activated by IgE-IC using calcium imaging. Different concentrations (0.01 ~ 1 µg/mL by antibody) of IgE-IC formed by mouse anti-OVA IgE (antibody) and OVA (antigen) were administrated to dissociated TG neurons via topical application. Antigen (OVA) or antibody (IgE) alone did not evoke any change in the [Ca 2+ ] i in TG neurons (Fig. 5A-B) . Application of IgE-IC dose-dependently evoked [Ca 2+ ] i increase in TG neurons from both naïve and OVA+alum sensitized mice (Fig. 5A-C 
DISCUSSION
Pruritus is the major symptoms of allergic conjunctivitis [28] [29] [30] , the most common form of ocular allergy that affects up to 40% population of the United States and 35% in Europe [31] [32] [33] . Although treatments targeting inflammatory mediators or immune cells such as antihistamine, mast cell stabilizer and steroid have been widely used to treat allergic pruritus, the results are often partially effective and unsatisfying [29, 30, [34] [35] [36] [37] [38] [39] . The present study showed that a mouse model of allergic ocular pruritus elicited ocular scratching with the hind-paw, an itch-but not pain-specific behavior. We found that topical application of OVA antigen elicited ocular itch-related behaviors in the OVA+alum sensitized mice with an increased serum level of antigen-specific IgE as well as IgG, but not in the OVA alone sensitized mice with increased serum level of IgG only. Therefore the binding of IgE and antigen, i.e. IgE-IC was required to produce ocular pruritus. In accord with our findings, site-specific scratching behaviors were also reported in previous studies of allergen-elicited ocular pruritus [40, 41] .
The scratching behavior could only be partially alleviated by pre-treatment with mast cell stabilizer or H 1 histamine receptor antagonist, but could be almost totally abolished by the FcεRI blocking antibody. These results are concordant with previous reports that cutaneous allergic itch in the mice could not be totally inhibited by H 1 histamine receptor antagonist and mast cell stabilizer [42, 43] , and indicate that allergic itch may involve factors other than inflammatory mediators and residential immune cells. Previous studies showed that mast cell that express the high-affinity IgE receptor
FcεRI can be directly activated via allergen (antigen) with IgE (allergen-specific), and play a key role in allergic itch. The cross-linking of IgE-IC to FcεRI on mast cells can trigger mast-cell degranulation, releasing inflammatory mediators such as histamine, tryptase, platelet-activating factor, prostaglandin E2 and TNF and so on. Theses mediators can activate the sensory terminal of peripheral nociceptive neurons therefore inducing itch or pain (Fig. 7A) . The present study revealed that FcεRI was expressed in mouse TG neurons, including those innervating the conjunctiva and those co-expressing pruriceptive neuronal markers MrgprA3 and MrgprD ( Supplementary Fig. S1 ).
We also found that IgE-IC induced calcium changes in certain small-sized TG neurons via neuronal FcεRI. Therefore, it is reasonable to propose that peripheral ocular endings of tentatively pruriceptive TG neurons expressing FcεRI can be directly activated by IgE-IC and contribute to allergen-induced ocular itch (Fig. 7B) . This hypothesis was supported by our behavioral results that pre-treatment of anti-FcεRI antibody almost completely abolished allergen-induced scratching. However, due to the presence of FcεRI in both immune cells and sensory neurons, the exact role of neuronal FcεRI in allergen-induced itch will need to be further investigated. Moreover, antigen-induced immune responses may evoke an acute phase (Type I hypersensitivity mainly mediated by IgE immune complex), and a delayed phase (Type IV hypersensitivity, mainly mediated by T-cells). In this study, we focus on the acute phase of allergic ocular itch that may involve the neuronal FcεR, although the antigen did evoke a delayed phase of itch-related behavior ( Figure 1J ). The potential role of FcεRI in the delayed phase will be explored in future studies.
The present study revealed that FcεRI (including α, β, and γ chains) was expressed in mouse TG neurons. It was reasonable to hypothesis that FcεRI was expressed on sensory neurons in tetrameric form (αβγ 2 ) as previously described in immune cells [7, 8, 10] . We found that the IgE binding chain FcεRIα showed the most significant upregulation after sensitization, but the underlying mechanisms and the role of each chain of neuronal FcεRI needs further investigation.
Recent studies showed the presence of Fc receptors including FcγR and FcεR in peripheral sensory neurons in the mice and rats [12, 14, 15, 21, 22, 25, 26] . IgG-IC may directly act on neuronal FcγRI, evoking [Ca 2+ ] i increase and action potential discharges in nociceptive DRG neurons [21, 22] . [17, 27] . The roles of sub-populations of IgE-IC responsive TG neurons in itch, and the molecular mechanisms underlying the neuronal-type specificity will be studied in the future.
Despite a upregulation of FcεRI in the TG from OVA-alum sensitized mice, there was no significant difference between naïve and OVA-alum sensitized mice in the amplitude of change in 
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